
Legal & General (1ARKW) | Stock Overview & Key Data
Legal & General Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €11.86 on August 26, 2013
Explore how other NL stocks compare to their 52-week ranges: View NL Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Legal & General 1ARKW | N/A Micro-cap | 4.79% | 8.04% | 16.57% | 51.15% | 36.81% | 90.65% | 3,840.00% | 2,264.00% |
UBS AG, London 0022U | N/A Micro-cap | 0.09% | 0.47% | 3.30% | 3.04% | 3.93% | 8.73% | 24.56% | 24.56% |
GLDFP 100PRO0825U 0110U | N/A Micro-cap | 0.08% | 0.35% | 1.16% | 2.41% | 2.94% | 6.55% | 22.72% | 22.72% |
MSCIW 103PRO0226U 0119U | N/A Micro-cap | -0.02% | -0.02% | 1.62% | 3.24% | 4.61% | 6.94% | 19.67% | 19.67% |
Ark Genomic 1ARKG | N/A Micro-cap | 8.94% | 11.43% | 16.77% | 6.56% | -1.02% | 3.72% | -96.66% | -96.93% |
1Ark Innovation 1ARKK | N/A Micro-cap | 6.57% | 10.36% | 20.32% | 44.57% | 28.62% | 68.78% | 49.20% | 153.74% |
Ownership & Short Interest
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is 1ARKW's 52-week high and low?
- In the last 52 weeks, Legal & General reached a high of €5.96 (on September 23, 2025) and a low of €3.03 (on October 3, 2024).
- What is the market cap and P/E ratio for 1ARKW?
- Curious about Legal & General's size and valuation? Its market capitalization stands at N/A. When it comes to valuation, the P/E ratio (trailing twelve months) is -0.12, and the forward P/E (looking ahead) is N/A.
- Does 1ARKW pay dividends? If so, what's the yield?
- As for dividends, Legal & General isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Legal & General's main competitors or similar companies to consider before investing?
When looking at Legal & General, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return UBS AG, London
0022UN/A N/A N/A 8.73% 24.56% GLDFP 100PRO0825U
0110UN/A N/A N/A 6.55% 22.72% MSCIW 103PRO0226U
0119UN/A N/A N/A 6.94% 19.67% Ark Genomic
1ARKGN/A N/A N/A 3.72% -96.66% 1Ark Innovation
1ARKKN/A N/A N/A 68.78% 49.20% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Legal & General Investment Management America ARK Next Gen Internet Trust? (e.g., ROE, Debt/Equity)
- To get a sense of Legal & General's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 38.07%, the Debt to Equity ratio from the most recent quarter is -0.30, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for 1ARKW?
- Looking at Legal & General's growth, its revenue over the trailing twelve months (TTM) was €24K. Compared to the same quarter last year (YoY), quarterly revenue grew by -199.33%, and quarterly earnings saw a YoY growth of N/A.
- How much of 1ARKW stock is held by insiders and institutions?
- Wondering who owns Legal & General stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.